ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 54 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $1,934,000 | -29.2% | 1,750,000 | -35.0% | 0.01% | -33.3% |
Q1 2020 | $2,732,000 | -19.2% | 2,693,000 | -8.7% | 0.02% | +23.5% |
Q4 2019 | $3,383,000 | -93.8% | 2,950,000 | -93.9% | 0.02% | -94.3% |
Q3 2019 | $54,824,000 | -3.8% | 48,113,000 | +0.1% | 0.30% | -5.4% |
Q2 2019 | $56,972,000 | +2.1% | 48,074,000 | +16.7% | 0.32% | -9.2% |
Q1 2019 | $55,801,000 | +85.2% | 41,197,000 | +47.1% | 0.35% | +74.9% |
Q4 2018 | $30,136,000 | +20.6% | 28,007,000 | +18.7% | 0.20% | +45.3% |
Q3 2018 | $24,993,000 | +7.9% | 23,600,000 | 0.0% | 0.14% | -3.5% |
Q2 2018 | $23,171,000 | -0.7% | 23,600,000 | 0.0% | 0.14% | -6.6% |
Q1 2018 | $23,343,000 | -6.7% | 23,600,000 | 0.0% | 0.15% | +18.8% |
Q4 2017 | $25,028,000 | +34.7% | 23,600,000 | +34.9% | 0.13% | -11.1% |
Q3 2017 | $18,584,000 | -0.3% | 17,500,000 | 0.0% | 0.14% | +4.3% |
Q2 2017 | $18,648,000 | +10.4% | 17,500,000 | 0.0% | 0.14% | +3.8% |
Q1 2017 | $16,898,000 | -5.6% | 17,500,000 | 0.0% | 0.13% | -6.3% |
Q4 2016 | $17,896,000 | +9.4% | 17,500,000 | 0.0% | 0.14% | +21.4% |
Q3 2016 | $16,353,000 | +32.2% | 17,500,000 | 0.0% | 0.12% | +34.5% |
Q2 2016 | $12,373,000 | -39.7% | 17,500,000 | -22.1% | 0.09% | -36.0% |
Q1 2016 | $20,529,000 | -19.1% | 22,479,000 | -0.1% | 0.14% | -15.5% |
Q4 2015 | $25,390,000 | – | 22,507,000 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|